Us Bancorp \De\ Innoviva, Inc. Transaction History

Us Bancorp \De\

$82.9 Billion
Q3 2025

A detailed history of Us Bancorp \De\ transactions in Innoviva, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,249 shares of INVA stock, worth $27,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,249

Previous 12,009 89.6%

Holding current value

$27,790

Previous $241,000 90.87%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$18.17 - $20.92 $195,509 - $225,099	-10,760 Reduced 89.6%	1,249 $22,000
Q2 2025 Jul 23, 2025	SELL	$17.1 - $21.8 $12,722 - $16,219	-744 Reduced 5.83%	12,009 $241,000
Q1 2025 May 08, 2025	BUY	$17.21 - $18.98 $171,342 - $188,964	9,956 Added 355.95%	12,753 $231,000
Q4 2024 Feb 05, 2025	SELL	$17.35 - $20.32 $1,353 - $1,584	-78 Reduced 2.71%	2,797 $48,000
Q3 2024 Oct 28, 2024	BUY	$16.33 - $20.04 $9,242 - $11,342	566 Added 24.51%	2,875 $55,000

Q2 2024 Aug 06, 2024	BUY	$14.4 - $16.4 $17,697 - $20,155	1,229 Added 113.8%	2,309 $37,000
Q1 2024 May 07, 2024	BUY	$14.56 - $16.78 $3,538 - $4,077	243 Added 29.03%	1,080 $16,000
Q4 2023 Feb 09, 2024	SELL	$12.32 - $16.27 $1,811 - $2,391	-147 Reduced 14.94%	837 $13,000
Q3 2023 Nov 03, 2023	BUY	$12.37 - $13.89 $1,026 - $1,152	83 Added 9.21%	984 $12,000
Q2 2023 Aug 09, 2023	BUY	$11.39 - $13.72 $1,400 - $1,687	123 Added 15.81%	901 $11,000
Q1 2023 May 09, 2023	BUY	$10.73 - $13.6 $6,223 - $7,888	580 Added 292.93%	778 $8,000
Q4 2022 Feb 13, 2023	SELL	$11.8 - $13.78 $1,404 - $1,639	-119 Reduced 37.54%	198 $2,000
Q3 2022 Oct 27, 2022	BUY	$11.61 - $15.22 $267 - $350	23 Added 7.82%	317 $4,000
Q2 2022 Aug 01, 2022	SELL	$14.32 - $19.88 $5,155 - $7,156	-360 Reduced 55.05%	294 $4,000
Q1 2022 May 11, 2022	BUY	$15.39 - $20.25 $430 - $567	28 Added 4.47%	654 $13,000
Q3 2021 Nov 10, 2021	BUY	$13.06 - $17.24 $587 - $775	45 Added 7.75%	626 $10,000
Q2 2021 Aug 05, 2021	BUY	$11.45 - $13.96 $6,652 - $8,110	581 New	581 $8,000
Q4 2020 Feb 04, 2021	SELL	$9.33 - $12.48 $9,404 - $12,579	-1,008 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$10.33 - $14.49 $2,479 - $3,477	-240 Reduced 19.23%	1,008 $11,000
Q2 2020 Aug 07, 2020	BUY	$11.49 - $15.26 $2,309 - $3,067	201 Added 19.2%	1,248 $17,000
Q1 2020 May 13, 2020	BUY	$8.11 - $15.23 $356 - $670	44 Added 4.39%	1,047 $12,000
Q3 2019 Nov 08, 2019	BUY	$10.05 - $14.55 $7,396 - $10,708	736 Added 275.66%	1,003 $11,000
Q2 2019 Aug 13, 2019	SELL	$13.1 - $14.95 $19,139 - $21,841	-1,461 Reduced 84.55%	267 $4,000
Q1 2019 May 08, 2019	BUY	$13.69 - $20.06 $20,001 - $29,307	1,461 Added 547.19%	1,728 $24,000
Q3 2017 Nov 13, 2017	BUY	$12.06 - $14.12 $3,220 - $3,770	267	267 $4,000

Others Institutions Holding INVA

# of Institutions

281

Shares Held

82.7M

Call Options Held

13.2K

Put Options Held

156K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account